SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-141826"
 

Search: onr:"swepub:oai:DiVA.org:umu-141826" > Anti-Mullerian horm...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Fortner, Renée T. (author)

Anti-Mullerian hormone and endometrial cancer : a multi-cohort study

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • 2017-09-05
  • Nature Publishing Group,2017
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-141826
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-141826URI
  • https://doi.org/10.1038/bjc.2017.299DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:136872973URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: The Mullerian ducts are the embryological precursors of the female reproductive tract, including the uterus; anti-Mullerian hormone (AMH) has a key role in the regulation of foetal sexual differentiation. Anti-Mullerian hormone inhibits endometrial tumour growth in experimental models by stimulating apoptosis and cell cycle arrest. To date, there are no prospective epidemiologic data on circulating AMH and endometrial cancer risk. Methods: We investigated this association among women premenopausal at blood collection in a multicohort study including participants from eight studies located in the United States, Europe, and China. We identified 329 endometrial cancer cases and 339 matched controls. AntiMullerian hormone concentrations in blood were quantified using an enzyme-linked immunosorbent assay. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CI) across tertiles and for a doubling of AMH concentrations (ORlog2). Subgroup analyses were performed by ages at blood donation and diagnosis, oral contraceptive use, and tumour characteristics. Results: Anti-Mullerian hormone was not associated with the risk of endometrial cancer overall (ORlog(2): 1.07 (0.99-1.17)), or with any of the examined subgroups. Conclusions: Although experimental models implicate AMH in endometrial cancer growth inhibition, our findings do not support a role for circulating AMH in the aetiology of endometrial cancer.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Schock, Helena (author)
  • Jung, Seungyoun (author)
  • Allen, Naomi E. (author)
  • Arslan, Alan A. (author)
  • Brinton, Louise A. (author)
  • Egleston, Brian L. (author)
  • Falk, Roni T. (author)
  • Gunter, Marc J. (author)
  • Helzlsouer, Kathy J. (author)
  • Idahl, AnnikaUmeå universitet,Obstetrik och gynekologi(Swepub:umu)anid0002 (author)
  • Johnson, Theron S. (author)
  • Kaaks, Rudolf (author)
  • Krogh, Vittorio (author)
  • Lundin, EvaUmeå universitet,Patologi(Swepub:umu)evlu0001 (author)
  • Merritt, Melissa A. (author)
  • Navarro, Carmen (author)
  • Onland-Moret, N. Charlotte (author)
  • Palli, Domenico (author)
  • Shu, Xiao-Ou (author)
  • Sluss, Patrick M. (author)
  • Staats, Paul N. (author)
  • Trichopoulou, Antonia (author)
  • Weiderpass, ElisabeteKarolinska Institutet (author)
  • Zeleniuch-Jacquotte, Anne (author)
  • Zheng, Wei (author)
  • Dorgan, Joanne F. (author)
  • Umeå universitetObstetrik och gynekologi (creator_code:org_t)

Related titles

  • In:British Journal of Cancer: Nature Publishing Group117:9, s. 1412-14180007-09201532-1827

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view